French Bio-Medical Laboratories / High Level Group / /
Continent
Europe / /
Currency
EUR / /
IndustryTerm
company law directives / company law system / company law directive / interest / case law / state company law system / extent company law / company law rules / company law / regulatory tool / company law restrictions / company law applying / communication technologies / class vis-àvis management / company law incorporation alternative / company law rights / objectives company law / implement company law mechanisms / electronic book-entry trading systems / legal infrastructure / /
NaturalFeature
Delaware / /
Organization
Court of Justice / UN Court / Community legislature / EUROPEAN COMMISSION / EU Commission / European Securities and Markets Authority / European Union / European Parliament / /
Person
Alain Pietrancosta / Peter Böckli / Michael Schouten / José Garrido / Paul Davies / Guido Ferrarini / Rolf Skog / Eddy Wymeersch / Klaus Hopt / Katharina Pistor / Joost Kloosterman / /
RESPONSE TO THE EUROPEAN COMMISSION’S CONSULTATION ON THE FUTURE OF EUROPEAN COMPANY LAW EUROPEAN COMPANY LAW EXPERTS Peter Böckli, Paul Davies, Eilis Ferran, Guido Ferrarini, José Garrido, Klaus Hopt, Alain Pietranc